Structure Therapeutics Inc.
GPCR
$23.74
$0.090.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.72% | -43.59% | -53.23% | -73.76% | -74.63% |
| Total Depreciation and Amortization | 215.19% | 173.91% | 114.38% | 68.95% | 14.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.28% | -48.05% | -42.16% | -86.34% | 45.71% |
| Change in Net Operating Assets | -57.45% | 63.61% | -291.77% | 774.90% | 134.70% |
| Cash from Operations | -46.73% | -46.02% | -72.10% | -76.26% | -72.35% |
| Capital Expenditure | 40.47% | -124.58% | -667.96% | -2,487.78% | -1,298.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.35% | -648.87% | -183.85% | -202.29% | -329.64% |
| Cash from Investing | -33.75% | -641.53% | -185.15% | -205.17% | -332.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.29% | 372.06% | 373.32% | 74.94% | 1,433,524.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.67% | -497.82% | -419.70% | -418.74% | -758.14% |
| Cash from Financing | 14.11% | 369.54% | 372.31% | 41.12% | 1,456.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.70% | 438.92% | 2,389.14% | -137.78% | 230.91% |